Table 1.
Lateral flow assay kits commercially available for COVID-19 diagnosis.
| Company | Kit name | Target | Features | Reference |
|---|---|---|---|---|
| MyLab Discovery Solutions | CoviSelf™ | Spike protein | Mobile app synchronized Time: 15 min |
[63] |
| Cellex Inc. | qSARS-CoV-2 IgG/IgM rapid test | IgG and IgM | Time: 15–20 min Sensitivity: 93.8% Specificity: 96% |
[64] |
| Luminostics, Inc. | Clip COVID rapid antigen test | Nucleocapsid protein | Time: 30 min | [65] |
| Pharmact AG | BELTEST-IT COV-2 | IgG and IgM | Sensitivity: IgM 98.1% and IgG 98.2% Specificity IgG 99.7% IgM 99.5% Time: 20 min |
[66] |
| Pharmact AG | BELTEST-IT AGS COV-2 | Not reported | Time: 15 min Sensitivity: 92.2% Specificity: 100% |
[67] |
| ChemBio Diagnostic System, Inc. | DPP COVID-19 IgM/IgG system | Nucleocapsid protein | Sensitivity: 93.5% Specificity: 94.4% Time: 15 min |
[68] |
| Celltrion | Celltrion DiaTrust™ | Nucleocapsid and receptor binding domains | Time: 15 min Specificity: 99.03% Sensitivity: 93.33% |
[69] |
| Acon | Flowflex™ SARS-CoV-2 | Nucleocapsid protein | Time: 15 min Sensitivity: 97.1% Specificity: 99.6% |
[70] |
| Xtrava Health | SPERA™ COVID-19 Ag test | Nucleocapsid protein | Time: 15 min Sensitivity: 92% Specificity: 97% |
[71] |
| ANP Technologies, Inc. | NIDS® COVID-19 antigen rapid test | Nucleocapsid protein | Time: 15 min | [72] |
| GenBody Inc. | GenBody COVID-19 Ag | Nucleocapsid protein | Time: 10–20 min Sensitivity: 96.8% Specificity: 98.9% |
[73] |
| InBios International, Inc. | SCoV-2 Ag Detect™ | Nucleocapsid protein | Time: 20 min Sensitivity: 86.67% Specificity: 100% |
[74] |
| Access Bio, Inc. | CareStart™ COVID-19 antigen home test | Nucleocapsid protein | Time: 10 min Sensitivity 93.8% Specificity 99.3% |
[75] |
| Becton, Dickinson and Company (BD) | BD Veritor™ at-home COVID-19 test | Nucleocapsid protein | Time: 15 min | [76] |